Septodont in the news

Straumann invests in MegaGen's growth, Colgate launches a recycling playground initiative, Dr. Bowen and Dr. Aravamudhan receive key dental awards, and Septodont is honored for its leadership and family values.

Biodentine is now validated for treating irreversible pulpitis, enabling minimally invasive vital pulp therapy and potentially avoiding root canals in most cases.

Septodont confirms that applying composite over Biodentine in one visit is effective and maintains restoration integrity after one year.

Septodont's Novocol Pharma secured $26 million from the Canadian government to boost biomanufacturing of sterile injectables at its Ontario facility.

Septodont acquired OraVerse anesthesia reversal drug from Novalar to expand its dental pain control offerings and market reach.

Septodont India manufactures and markets innovative, high-quality dental anesthesia and restorative products tailored for the price-sensitive Indian market, with plans to expand local production and reach.

Biodentine by Septodont is a bioactive calcium silicate material used for conservative pulp capping that preserves tooth vitality and stimulates dentin formation.

Septodont's Ultra Safety Plus XL syringe offers a safer, more comfortable dental anesthesia experience with BDA accreditation and enhanced injection capabilities.

Dentapen is a cordless electronic syringe that reduces pain and improves control during dental injections.

Septodont, a dental drug and medical device company, is heavily impacted by rising energy prices, leading to a visit from Roland Lescure.

Septodont, a dental drug and medical device company, is heavily impacted by rising energy prices.

Septodont Holdings' global employee count reached 1,031 in March 2026, marking an 8.5% increase since 2023.

Septodont North America introduces Flavalta, a flavored lidocaine formulation with epinephrine, designed for dental anesthesia with maintained clinical performance.

Septodont has developed Flavalta, a flavored lidocaine, to solve the long-standing issue of the bitter taste associated with the standard dental anesthetic.

Septodont, a family-owned French company, founded in 1932, is the global leader in dental anesthesia, with recent acquisitions and plans for significant revenue growth by 2032.

Septodont, a dental anesthesia manufacturer, is heavily impacted by rising energy costs, as highlighted during a visit by Roland Lescure on October 14, 2022.

French Industry Minister Roland Lescure visited dental manufacturer Septodont to discuss the impact of rising energy costs on medical device production.

Septodont is partnering with Dentroid to develop and commercialize Nuralyte, a light-based dental device designed to replace traditional anesthetic needles.

Septodont is partnering with Australian startup Dentroid to develop and commercialize noninvasive dental pain management technology using photonics and robotics.

Strategic partnership to develop and commercialize Nuralyte, a light-based device for needle-free dental pain management.